Compare McKesson Corporation (MCK) vs Oklo Inc (OKLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Oklo Inc — how do they compare? McKesson Corporation trades at $894.34 (market cap $105.14B), while Oklo Inc trades at $45.18 (market cap $8.74B). The key difference: McKesson Corporation is far larger — about 12× Oklo Inc's market cap, and McKesson Corporation pays a 0.42% dividend while Oklo Inc pays none. Which is the better fit depends on your goals.
| MCK | OKLO | |
|---|---|---|
Market Cap | $105.14B | $8.74B |
Sector | Health | Technology |
52-Week High | $995.69 | $174.14 |
52-Week Low | $659.01 | $36.84 |
Enterprise Value | $111.67B | $6.28B |
Dividend Yield | 0.42% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson (MCK) trades at $879.87, up 1.18% today, with strong momentum from recent earnings beats and raised guidance. The stock shows bullish technical signals, supported by robust revenue growth and solid cash flow generation. Recent news highlights strength in specialty drugs and oncology, driving positive sentiment.
Outlook remains favorable with a consensus price target of $990.67, though thin profit margins and high liabilities pose risks. Continued execution on growth initiatives and cost discipline are key for sustained upside, while macroeconomic pressures and competitive dynamics require monitoring.
OKLO trades at $46.41, up 4.32% over 24 hours, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $77.07. The company reported its first revenue of $1.2 million in Q2 2026 but continues to post significant losses, with a net income margin of -12,625.54% in 2026. Recent milestones include achieving first criticality at its Groves isotope reactor, though cash burn remains high as it advances Aurora nuclear projects.
Outlook is speculative with high growth potential in nuclear energy infrastructure, but risks include persistent losses, execution challenges, and reliance on financing. Analyst sentiment is strongly bullish (76.9% buy ratings), yet investors must weigh the long-term payoff against near-term financial instability and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Oklo Inc
Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →
